Truist initiated coverage on Curis with a new price target
$CRIS
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Truist initiated coverage of Curis with a rating of Buy and set a new price target of $26.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/19/2025 | $17.00 | Buy | H.C. Wainwright |
| 11/17/2023 | $26.00 | Buy | Truist |
| 4/4/2022 | Outperform → Mkt Perform | Raymond James | |
| 10/13/2021 | $15.00 | Outperform | Raymond James |
8-K - CURIS INC (0001108205) (Filer)
EFFECT - CURIS INC (0001108205) (Filer)
10-Q - CURIS INC (0001108205) (Filer)